MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216

Por Reijers, Joannes A. A., Kallend, D. G., Malone, K. E., Jukema, J. W., Wijngaard, P. L. J., Burggraaf, J., Moerland, M.
Publicado no Cardiovasc Drugs Ther (2017)

A single infusion of MDCO-216 (ApoA-1 Milano/POPC) increases ABCA1-mediated cholesterol efflux and pre-beta 1 HDL in healthy volunteers and patients with stable coronary artery dis...

Por Kallend, D.G., Reijers, J.A.A., Bellibas, S.E., Bobillier, A., Kempen, H., Burggraaf, J., Moerland, M., Wijngaard, P.L.J.
Publicado no Eur Heart J Cardiovasc Pharmacother (2016)